The effect of nitecapone, a new antioxidant, on myocardial function after aortic cross-clamping in experimental heart ischemia

[1]  G. Buckberg,et al.  Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. , 1995, The Journal of thoracic and cardiovascular surgery.

[2]  G. Buckberg.  Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. , 1995, The Journal of thoracic and cardiovascular surgery.

[3]  L. Packer,et al.  Role of ascorbate in protection by nitecapone against cardiac ischemia-reperfusion injury. , 1995, Biochemical pharmacology.

[4]  R. Ferrari.  Metabolic disturbances during myocardial ischemia and reperfusion. , 1995, The American journal of cardiology.

[5]  P. Kovanen,et al.  Inhibition of the Oxidative Modification of LDL by Nitecapone , 1995 .

[6]  I. Lindén,et al.  Antioxidant properties of nitecapone are potentiated by glutathione. , 1995, Biochemistry and molecular biology international.

[7]  T. Vasankari,et al.  Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[8]  M. Ahotupa,et al.  Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting. , 1994, The Journal of thoracic and cardiovascular surgery.

[9]  M. Rorarius,et al.  The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. , 1994, Free radical biology & medicine.

[10]  L. Packer,et al.  Antioxidant activity of nitecapone and its analog OR-1246: effect of structural modification on antioxidant action. , 1994, Methods in enzymology.

[11]  L. Packer,et al.  Nitecapone protects the Langendorff perfused heart against ischemia-reperfusion injury. , 1993, Biochemistry and molecular biology international.

[12]  L. Packer,et al.  Antioxidant properties of nitecapone (OR-462). , 1992, Free radical biology & medicine.

[13]  K. Prasad,et al.  Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. , 1992, American heart journal.

[14]  P. Reilly,et al.  Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. , 1991, American journal of surgery.

[15]  M. Scheinin,et al.  Exercise hemodynamics and catecholamine metabolism after catechol‐O‐methyltransferase inhibition with nitecapone , 1990, Clinical pharmacology and therapeutics.

[16]  P. Menasche,et al.  Free radicals and myocardial protection: a surgical viewpoint. , 1989, The Annals of thoracic surgery.

[17]  M. Weisfeldt,et al.  Direct measurement of free radical generation following reperfusion of ischemic myocardium , 1987 .

[18]  A. Rizzi,et al.  Influence of the stationary phase on the retention characteristics of purine and pyrimidine bases, ribonucleosides and deoxyribonucleosides in reversed-phase high-performance liquid chromatography , 1985 .

[19]  R. Bird,et al.  Comparative studies on different methods of malonaldehyde determination. , 1984, Methods in enzymology.

[20]  A. Milia,et al.  Carbon tetrachloride, bromotrichloromethane and ethanol acute intoxication. New chemical evidence for lipid peroxidation in rat tissue microsomes. , 1983, The Biochemical journal.